levetiracetam and Dementia--Vascular

Seizures constitute a determining aspect in quality of life and are frequently challenging in palliative care-a field where treatment has yet to be standardised. Levetiracetam-a new generation anticonvulsant-has proved efficacy both through oral, as well as intravenous administration in the general population. This case reports on the use of continuous subcutaneous levetiracetam to effectively control seizures in a terminally ill patient without patent oral route.

Topics: Aged, 80 and over; Anticonvulsants; Dementia, Vascular; Disease Progression; Female; Humans; Infusions, Subcutaneous; Levetiracetam; Piracetam; Quality of Life; Seizures; Terminal Care; Treatment Outcome